The COVID-19 pandemic forced a number of changes, many of which will remain in place long after it subsides. One important but under-recognized shift could be in the field of clinical diagnostics.

The scope of real-time quantitative (qPCR) assays for gene-expression analysis in research applications and for sequence-specific nucleic acid detection for diagnostic purposes continues to grow.